Literature DB >> 28771893

MRI Interscanner Agreement of the Association between the Susceptibility Vessel Sign and Histologic Composition of Thrombi.

Romain Bourcier1, Lili Détraz1, Jean Michel Serfaty2,3, Beatrice Guyomarch Delasalle4, Mahmood Mirza5, Imad Derraz6, Frédérique Toulgoat7, Olivier Naggara8,9, Claire Toquet10, Hubert Desal1.   

Abstract

BACKGROUND AND
PURPOSE: The susceptibility vessel sign (SVS) on magnetic resonance imaging (MRI) is related to thrombus location, composition, and size in acute stroke. No previous study has determined its inter-MRI scanner variability. We aimed to compare the diagnostic accuracy in-vitro of four different MRI scanners for the characterization of histologic thrombus composition.
METHODS: Thirty-five manufactured thrombi analogs of different composition that were histologically categorized as fibrin-dominant, mixed, or red blood cell (RBC)-dominant were scanned on four different MRI units with T2* sequence. Nine radiologists, blinded to thrombus composition and MRI scanner model, classified twice, in a 2-week interval, the SVS of each thrombus as absent, questionable, or present. We calculated the weighted kappa with 95% confidence interval (CI), sensitivity, specificity and accuracy of the SVS on each MRI scanner to detect RBC-dominant thrombi.
RESULTS: The SVS was present in 42%, absent in 33%, and questionable in 25% of thrombi. The interscanner agreement was moderate to good, ranging from .45 (CI: .37-.52) to .67 (CI: .61-.74). The correlation between the SVS and the thrombus composition was moderate (κ: .50 [CI: .44-.55]) to good κ: .76 ([CI: .72-.80]). Sensitivity, specificity, and accuracy to identify RBC-dominant clots were significantly different between MRI scanners (P < .001).
CONCLUSION: The diagnostic accuracy of SVS to determine thrombus composition varies significantly among MRI scanners. Normalization of T2*sequences between scanners may be needed to better predict thrombus composition in multicenter studies.
Copyright © 2017 by the American Society of Neuroimaging.

Entities:  

Keywords:  MRI interscanner agreement; SVS; Stroke; T2* sequence

Mesh:

Year:  2017        PMID: 28771893     DOI: 10.1111/jon.12464

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  10 in total

Review 1.  Correlation of imaging and histopathology of thrombi in acute ischemic stroke with etiology and outcome: a systematic review.

Authors:  Waleed Brinjikji; Sharon Duffy; Anthony Burrows; Werner Hacke; David Liebeskind; Charles B L M Majoie; Diederik W J Dippel; Adnan H Siddiqui; Pooja Khatri; Blaise Baxter; Raul Nogeuira; Matt Gounis; Tudor Jovin; David F Kallmes
Journal:  J Neurointerv Surg       Date:  2016-05-10       Impact factor: 5.836

2.  MRI Quantitative T2* Mapping to Predict Dominant Composition of In Vitro Thrombus.

Authors:  R Bourcier; R Pautre; M Mirza; C Castets; J Darcourt; J Labreuche; L Detraz; H Desal; J-M Serfaty; C Toquet
Journal:  AJNR Am J Neuroradiol       Date:  2019-01       Impact factor: 3.825

3.  Susceptibility Vessel Sign and Cardioembolic Etiology in the THRACE Trial.

Authors:  Romain Bourcier; Imad Derraz; Béatrice Delasalle; Marine Beaumont; Sebastien Soize; Laurence Legrand; Hubert Desal; Serge Bracard; Olivier Naggara; Catherine Oppenheim
Journal:  Clin Neuroradiol       Date:  2018-06-12       Impact factor: 3.649

4.  Validation of overestimation ratio and TL-SVS as imaging biomarker of cardioembolic stroke and time from onset to MRI.

Authors:  Romain Bourcier; Laurence Legrand; Sébastien Soize; Julien Labreuche; Marine Beaumont; Hubert Desal; Imad Derraz; Serge Bracard; Catherine Oppenheim; Olivier Naggara
Journal:  Eur Radiol       Date:  2018-11-12       Impact factor: 5.315

5.  Two-Layered Susceptibility Vessel Sign and High Overestimation Ratio on MRI Are Predictive of Cardioembolic Stroke.

Authors:  R Bourcier; I Derraz; S Bracard; C Oppenheim; O Naggara
Journal:  AJNR Am J Neuroradiol       Date:  2018-11-15       Impact factor: 3.825

Review 6.  Correlation of imaging and histopathology of thrombi in acute ischemic stroke with etiology and outcome.

Authors:  Seán Fitzgerald; Oana M Mereuta; Karen M Doyle; Daying Dai; Ramanathan Kadirvel; David F Kallmes; Waleed Brinjikji
Journal:  J Neurosurg Sci       Date:  2018-12-05       Impact factor: 2.279

7.  Clot Burden Score and Collateral Status and Their Impact on Functional Outcome in Acute Ischemic Stroke.

Authors:  I Derraz; M Pou; J Labreuche; L Legrand; S Soize; M Tisserand; C Rosso; M Piotin; G Boulouis; C Oppenheim; O Naggara; S Bracard; F Clarençon; B Lapergue; R Bourcier
Journal:  AJNR Am J Neuroradiol       Date:  2020-11-12       Impact factor: 3.825

8.  Susceptibility Vessel Sign in the ASTER Trial: Higher Recanalization Rate and More Favourable Clinical Outcome after First Line Stent Retriever Compared to Contact Aspiration.

Authors:  Romain Bourcier; Mickael Mazighi; Julien Labreuche; Robert Fahed; Raphael Blanc; Benjamin Gory; Alain Duhamel; Gaultier Marnat; Suzana Saleme; Vincent Costalat; Serge Bracard; Hubert Desal; Arturo Consoli; Michel Piotin; Bertrand Lapergue
Journal:  J Stroke       Date:  2018-05-31       Impact factor: 6.967

9.  Does Clot Burden Score on Baseline T2*-MRI Impact Clinical Outcome in Acute Ischemic Stroke Treated with Mechanical Thrombectomy?

Authors:  Imad Derraz; Romain Bourcier; Marc Soudant; Sébastien Soize; Wagih Ben Hassen; Gabriella Hossu; Frederic Clarencon; Anne Laure Derelle; Marie Tisserand; Helene Raoult; Laurence Legrand; Serge Bracard; Catherine Oppenheim; Olivier Naggara
Journal:  J Stroke       Date:  2019-01-31       Impact factor: 6.967

Review 10.  Thrombus Composition and Efficacy of Thrombolysis and Thrombectomy in Acute Ischemic Stroke.

Authors:  Precious Jolugbo; Robert A S Ariëns
Journal:  Stroke       Date:  2021-02-10       Impact factor: 7.914

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.